Triple Incretin Activation with Mitochondrial Metabolic Restoration
Mechanistic Synergy for Research:
- Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, resulting in unmatched metabolic stimulation, appetite regulation, and energy expenditure in preclinical models.
- NAD⁺ supports cellular energy generation and mitochondrial dynamics, enhancing the metabolic impact of triple agonist activity.
Combined Benefits:
- Retatrutide promotes thermogenesis and fatty acid oxidation; NAD⁺ sustains ATP production and sirtuin-mediated gene expression for insulin sensitivity and mitochondrial repair.
- This combination improves metabolic flexibility and enhances intracellular glucose and lipid handling.
Use Cases:
Advanced obesity and thermogenesis models, triple incretin synergy research, mitochondrial dysfunction studies.
